Summary of Key Information:

Reporting Period: Quarter and Half Year ended September 30, 2026

Nature of Filing / Announcement: Outcome of Board Meeting - Financial Results under SEBI Listing Regulations

Audit Opinion:

Unmodified opinion issued by Agiwal & Associates, Chartered Accountants (FRN: 000181N)

Key Financial Highlights [₹ in millions]:

Consolidated Results:

Quarter Ended September 30, 2026:

  • Revenue from Operations: ₹8,089.79
  • Other Income: ₹172.75
  • Total Income: ₹10,040.09
  • Total Expenses: ₹6,506.50
  • Profit Before Tax: ₹1,732.35
  • Tax Expenses: ₹290.63
  • Net Profit: ₹1,441.72
  • EPS: ₹3.31 (Basic, not annualized)

Half Year Ended September 30, 2026:

  • Revenue from Operations: ₹16,793.56
  • Other Income: ₹316.09
  • Total Income: ₹17,109.65
  • Total Expenses: ₹13,563.81
  • Profit Before Tax: ₹3,545.84
  • Tax Expenses: ₹810.27
  • Net Profit: ₹2,735.57
  • EPS: ₹6.87 (Basic, not annualized)

Comparative Performance (Q2 YoY):

  • Revenue from Operations: Increased from ₹4,102.01 million (Q2 2025) to ₹8,089.79 million (Q2 2026)
  • Net Profit: Increased from ₹787.04 million (Q2 2025) to ₹1,441.72 million (Q2 2026)

Standalone Results:

Quarter Ended September 30, 2026:

  • Revenue from Operations: ₹340.84
  • Other Income: ₹41.70
  • Total Income: ₹382.54
  • Total Expenses: ₹388.36
  • Net Loss: ₹(0.57)
  • EPS: ₹(0.02) (Basic, not annualized)

Half Year Ended September 30, 2026:

  • Revenue from Operations: ₹758.62
  • Other Income: ₹88.38
  • Total Income: ₹847.00
  • Total Expenses: ₹753.30
  • Net Profit: ₹93.70
  • EPS: ₹0.01 (Basic, not annualized)

Segment-wise Performance:

The Group operates in a single reportable business segment "Healthcare Service" primarily in India. No segment-wise breakdown provided.

Corporate Actions:

  • No dividend declared
  • No share split, bonus issue, or buyback announced

Other Significant Information:

Acquisitions and Expansion:

1. Acquired 80% stake in V3 Healthcare Private Limited on July 31, 2026 for approximately ₹1,628.40 million

  • Operates "The Medicity Hospital" in Rudrapur, Uttarakhand (330 beds)
  • Remaining 20% to be acquired by April 30, 2030
  • Hospital launched under current management on August 2, 2026

2. Incorporated wholly owned subsidiary Park Medicity Prayagraj Limited on September 08, 2026

  • For development and operation of 550-bed multi-super speciality hospital in Prayagraj, UP
  • Awarded under PPP model by Prayagraj Municipal Corporation

3. Aggarwal Hospital and Research Services Private Limited (wholly owned subsidiary) entered into operation and management agreement with Axis Educational Society

  • To operate and manage 300-bed multi-super speciality hospital in Kanpur, UP
  • 28-year term effective April 01, 2027

4. Board approved acquisition of 100% stake in Mehar Mediserve LLP by December 03, 2026

  • Owns Mehar Hospital in Zirakpur, Punjab (150+ beds)

IPO Proceeds Utilization (Revised):

Total IPO proceeds: ₹7,132.77 million fully utilized as follows:

  • ₹3,800.00 million: Repayment/prepayment of borrowings
  • ₹195.19 million: Capital expenditure for new hospital development
  • ₹36.08 million: Purchase of medical equipment
  • ₹2,453.18 million: Unidentified inorganic acquisitions and general corporate purposes
  • ₹648.32 million: Acquisition of The Medicity Hospital, Rudrapur

Financial Position (Consolidated):

As at September 30, 2026:

  • Total Assets: ₹32,110.90 million
  • Equity Share Capital: ₹863.86 million
  • Other Equity: ₹19,235.98 million
  • Non-Current Liabilities: ₹3,010.35 million
  • Current Liabilities: ₹6,299.93 million
  • Cash and Cash Equivalents: ₹762.23 million

Cash Flow (H1 FY27):

  • Net cash used in operating activities: ₹(1,598.85) million
  • Net cash used in investing activities: ₹(1,572.53) million
  • Net cash from financing activities: ₹1,939.33 million
  • Net decrease in cash: ₹(1,636.69) million

Entities in Consolidation:

The consolidated results include 25 subsidiaries and step-down subsidiaries as listed in Annexure-I, including:

  • Park Medicentres & Institutions Private Limited
  • Aggarwal Hospital & Research Services Private Limited
  • Park Medicity India Private Limited
  • V3 Health Care Private Limited
  • Park Medicity Prayagraj Private Limited
  • Devina Derma Private Limited (ceased to be subsidiary from June 05, 2026 due to divestment)

Auditor's Limited Review Scope:

  • 20 subsidiaries reviewed by other auditors (total assets: ₹23,061.20 million)
  • 3 subsidiaries not reviewed by their auditors (total assets: ₹961.18 million, considered not material)